MEIP logo

MEI Pharma (MEIP) Company Overview

Profile

Full Name:

MEI Pharma, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 18, 2003

Indexes:

Not included

Website:

http://meipharma.com

Description:

MEI Pharma is a biotechnology company focused on developing innovative therapies for cancer treatment. They work on creating new drugs that target specific cancer cells, aiming to improve patient outcomes and quality of life. Their research includes both clinical trials and partnerships with other organizations in the healthcare field.

Key Details

Price

$2.77

Market Cap

$18.49 M(Small cap)

Last Dividend

$1.75

TTM Dividend Yield

-

Annual Revenue

$65.30 M(+33.76% YoY)

Annual EPS

$2.67(+155.86% YoY)

PE Ratio

-

Annual ROE

61.68%

Annual Debt To Equity

0.00

Beta

0.50

Events Calendar

Earnings

Next earnings date:

Feb 13, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Sep 19, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Nov 16, 2023
Splits

Next split:

N/A

Recent split:

Apr 17, 2023

Analyst ratings

Recent major analysts updates

Jul 23, 24 Laidlaw & Co.
Hold
Apr 12, 24 Stifel
Hold
Feb 14, 24 Stifel
Hold
Sep 27, 23 Stifel
Hold
May 23, 23 Brookline Capital
Buy
May 12, 23 Stifel
Hold
Feb 13, 23 HC Wainwright & Co.
Buy
Feb 8, 23 Jefferies
Underperform
Dec 6, 22 Truist Securities
Hold
Dec 6, 22 BTIG
Neutral

Screeners with MEIP included

US stocks
Stocks below SMA 200
Stocks recommended to hold
Stocks above SMA 50
Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Earnings next week
Moving average channel strategy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$2.77
MEIP price is $2.77

Price All-time High

$15324.00
MEIP price is currently -99.98% below its historical high of $15324.00

Price Analysts Target

-
MEIP price consensus analysts' forecast is unknown

Price Today Change

-1.25%
MEIP price is down -1.25% today

Price YTD Change

+12.8%
MEIP price is up +12.8% since January 1st

Price 3-Year Change

-92.46%
MEIP price is down -92.46% over the past 3 years

Market cap

Market Cap

$18.49 M
MEIP market capitalization is $18.49 million

Market Cap 3-Year Change

-92.44%
MEIP market capitalization is down -92.44% over the past 3 years

Market Cap All-time High

$726.36 M
MEIP market capitalization is currently -97.45% below its historical high of $726.36 million

Market Cap Sector Rank

23.74%
MEIP market capitalization is higher than 23.74% of companies in Healthcare sector

Technical

Beta

0.50
MEIP beta is 0.50

200-day SMA

$2.94
MEIP price is currently -5.59% below its 200-day simple moving average

14-day RSI

50.89
MEIP 14-day relative strength index is 50.89

30-day Relative Volume

0.82
MEIP 30-day relative volume is 0.82

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$1.75
MEIP last dividend was $1.75 per share, with an ex-dividend date of November 16, 2023

Next Dividend

-
MEIP next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

$1.75
MEIP annual dividend per share is $1.75

Annual Dividend Per Share Sector Rank

67.09%
MEIP annual dividend per share is higher than 67.09% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

-
MEIP annual dividend per share 1-year change is unknown

Annual Dividend Per Share 3-Year Change

-
MEIP annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

63.06%
MEIP annual dividend yield is 63.06%

Annual Dividend Yield Sector Rank

100%
MEIP annual dividend yield is higher than 100% of companies in Healthcare sector

Other

Annual Payout Ratio

65.59%
MEIP annual payout ratio is 65.59%

Annual Dividends Paid

$11.66 M
MEIP annual dividends paid is $11.66 million

Annual FCF

-$50.48 M
MEIP annual free cash flow is -$50.48 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$65.30 M
MEIP annual revenue is $65.30 million

Annual Revenue Analysts Estimate

-
MEIP annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

+33.76%
MEIP annual revenue is up +33.76% year-on-year

Annual Revenue Sector Rank

51.58%
MEIP annual revenue is higher than 51.58% of companies in Healthcare sector

Profit

Annual Gross Profit

-
MEIP annual gross profit value is unknown

Annual Gross Margin

-
MEIP annual gross profit margin value is unknown

Annual Operating Profit

$25.44 M
MEIP annual operating income is $25.44 million

Annual Operating Margin

38.96%
MEIP annual operating profit margin is 38.96%

Annual Net Income

$17.78 M
MEIP annual net profit is $17.78 million

Annual Net Margin

27.23%
MEIP annual net profit margin is 27.23%

EPS

Annual EPS

$2.67
MEIP annual earnings per share is $2.67

Annual EPS Analysts Estimate

-$4.62
MEIP annual earnings per share is currently -157.79% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+155.86%
MEIP annual earnings per share is up +155.86% year-on-year

Annual EPS Sector Rank

93.32%
MEIP annual earnings per share is higher than 93.32% of companies in Healthcare sector

ROA & ROE

Annual ROA

21.92%
MEIP annual return on assets is 21.92%

Annual ROE

61.68%
MEIP annual return on equity is 61.68%

EBIT & EBITDA

Annual EBIT

$25.44 M
MEIP annual earnings before interest & taxes is $25.44 million

Annual EBITDA

$25.82 M
MEIP annual EBITDA is $25.82 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
MEIP price to earnings ratio value is unknown

PE Ratio Sector Rank

-
MEIP price to earnings ratio is unknown

PB Ratio

PB Ratio

0.74
MEIP price to book ratio is 0.74

PB Ratio Sector Rank

34.48%
MEIP price to book ratio is higher than 34.48% of companies in Healthcare sector

PS Ratio

PS Ratio

-
MEIP price to sales ratio value is unknown

PS Ratio Sector Rank

-
MEIP price to sales ratio is unknown

Enterprise value

Enterprise Value

$11.54 M
MEIP enterprise value is $11.54 million

Enterprise Value Sector Rank

23.87%
MEIP enterprise value is higher than 23.87% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.31
MEIP EV/EBITDA is -0.31

EV/EBITDA Sector Rank

59.06%
MEIP EV/EBITDA is higher than 59.06% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

4.88
MEIP annual current ratio is 4.88

Annual Quick Ratio

-
MEIP annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
MEIP annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
MEIP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
MEIP piotroski f-score value is unknown

Altman Z-Score

-7.26
MEIP altman z-score is -7.26

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$41.38 M
MEIP annual total assets is $41.38 million

Annual Non Current Assets

$606.00 K
MEIP annual long term assets is $606.00 thousand

Annual Current Assets

$40.77 M
MEIP annual total current assets is $40.77 million

Annual Cash & Cash Equivalents

$3.71 M
MEIP annual cash & cash equivalents is $3.71 million

Equity

Annual Book Value

$33.02 M
MEIP annual book value is $33.02 million

Annual Working Capital

$32.41 M
MEIP annual working capital is $32.41 million

Liabilities

Annual Total Liabilities

$8.36 M
MEIP annual total liabilities is $8.36 million

Annual Total Long Term Liabilities

$0.00
MEIP annual total long term liabilities is $0.00

Annual Current Liabilities

$8.36 M
MEIP annual total current liabilities is $8.36 million

Annual Accounts Payable

$3.17 M
MEIP annual accounts payable is $3.17 million

Debt

Annual Total Debt

$0.00
MEIP annual total debt is $0.00

Annual Total Debt 1-Year Change

-100%
MEIP annual total debt is down -100% year-on-year

Annual Long Term Debt

$0.00
MEIP annual long term debt is $0.00

Annual Short Term Debt

$0.00
MEIP annual short term debt is $0.00

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$39.86 M
MEIP annual total expenses is $39.86 million

Annual Operating Expenses

$39.86 M
MEIP annual total operating expenses is $39.86 million

Annual Cost Of Goods Sold

-
MEIP annual cost of goods sold value is unknown

Annual SGA

$23.30 M
MEIP annual SGA is $23.30 million

Annual D&A

$383.00 K
MEIP annual depreciation & amortization is $383.00 thousand

Annual Interest Expense

-
MEIP annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$50.47 M
MEIP annual cash flow from operations is -$50.47 million

Annual CFO 1-Year Change

+3.83%
MEIP annual cash flow from operations is up +3.83% year-on-year

Annual CFI

$49.14 M
MEIP annual cash flow from investing activities is $49.14 million

Annual CFI 1-Year Change

-8.47%
MEIP annual cash flow from investing activities is down -8.47% year-on-year

Annual CFF

-$11.87 M
MEIP annual cash flow from financing activities is -$11.87 million

Annual CFF 1-Year Change

-29570%
MEIP annual cash flow from financing activities is down -29570% year-on-year

Free CashFlow

Annual FCF

-$50.48 M
MEIP annual free cash flow is -$50.48 million

Annual FCF 1-Year Change

+3.88%
MEIP annual free cash flow is up +3.88% year-on-year

CAPEX

Annual CAPEX

$7000.00
MEIP annual capital expenditures is $7000.00

Annual CAPEX 1-Year Change

-80%
MEIP annual capital expenditures is down -80% year-on-year

Institutional Ownership

Similar stocks

BOLT logo
Bolt Biotherapeutics (BOLT)
ATHA logo
Athira Pharma (ATHA)
SLGL logo
Sol-Gel Technologies (SLGL)
CRVO logo
CervoMed (CRVO)
FNCH logo
Finch Therapeutics (FNCH)
CDIO logo
Cardio Diagnostics Holdings (CDIO)
SABS logo
SAB Biotherapeutics (SABS)
Kairos Pharma (KAPA)
COCP logo
Cocrystal Pharma (COCP)
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
MEI Pharma, Inc. (MEIP) Reports Q2 Loss, Misses Revenue Estimates
MEIP
Zacks Investment ResearchFebruary 13, 2024

MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $1.66 per share versus the Zacks Consensus Estimate of a loss of $1.46. This compares to earnings of $1.60 per share a year ago.

All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy
All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy
All You Need to Know About MEI Pharma, Inc. (MEIP) Rating Upgrade to Strong Buy
MEIP
Zacks Investment ResearchSeptember 29, 2023

MEI Pharma, Inc. (MEIP) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript
MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript
MEI Pharma, Inc. (MEIP) Q4 2023 Earnings Call Transcript
MEIP
Seeking AlphaSeptember 26, 2023

MEI Pharma, Inc. (NASDAQ:MEIP ) Q4 2023 Earnings Call Transcript September 26, 2023 5:00 PM ET Company Participants David Walsey - SVP, Corporate Affairs David Urso - President & CEO Jay File - CFO Richard Ghalie - CMO Conference Call Participants Yale Jen - Laidlaw & Company Stephen Willey - Stifel Operator Good day and welcome to the MEI Fiscal Year-End Earnings Call. My name is Gary and I will be the conference facilitator today.

MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates
MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates
MEI Pharma, Inc. (MEIP) Reports Q3 Loss, Tops Revenue Estimates
MEIP
Zacks Investment ResearchMay 11, 2023

MEI Pharma, Inc. (MEIP) came out with a quarterly loss of $2.32 per share versus the Zacks Consensus Estimate of a loss of $2.60. This compares to loss of $3.40 per share a year ago.

FAQ

  • What is the ticker symbol for MEI Pharma?
  • Does MEI Pharma pay dividends?
  • What sector is MEI Pharma in?
  • What industry is MEI Pharma in?
  • What country is MEI Pharma based in?
  • When did MEI Pharma go public?
  • Is MEI Pharma in the S&P 500?
  • Is MEI Pharma in the NASDAQ 100?
  • Is MEI Pharma in the Dow Jones?
  • When was MEI Pharma's last earnings report?
  • When does MEI Pharma report earnings?
  • Should I buy MEI Pharma stock now?

What is the ticker symbol for MEI Pharma?

The ticker symbol for MEI Pharma is NASDAQ:MEIP

Does MEI Pharma pay dividends?

No, MEI Pharma does not pay dividends

What sector is MEI Pharma in?

MEI Pharma is in the Healthcare sector

What industry is MEI Pharma in?

MEI Pharma is in the Biotechnology industry

What country is MEI Pharma based in?

MEI Pharma is headquartered in United States

When did MEI Pharma go public?

MEI Pharma's initial public offering (IPO) was on December 18, 2003

Is MEI Pharma in the S&P 500?

No, MEI Pharma is not included in the S&P 500 index

Is MEI Pharma in the NASDAQ 100?

No, MEI Pharma is not included in the NASDAQ 100 index

Is MEI Pharma in the Dow Jones?

No, MEI Pharma is not included in the Dow Jones index

When was MEI Pharma's last earnings report?

MEI Pharma's most recent earnings report was on Nov 12, 2024

When does MEI Pharma report earnings?

The next expected earnings date for MEI Pharma is Feb 13, 2025

Should I buy MEI Pharma stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions